| scholarly article | Q13442814 |
| P2093 | author name string | Antony Rosen | |
| Marjan Gucek | |||
| Xiaoming Zhu | |||
| Felipe Andrade | |||
| Erika Darrah | |||
| Robert N Cole | |||
| P2860 | cites work | Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study | Q21195665 |
| Histone deimination antagonizes arginine methylation | Q24302163 | ||
| Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4 | Q24310773 | ||
| Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 | Q24538382 | ||
| Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies | Q24564876 | ||
| Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis | Q28183279 | ||
| Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes | Q28210002 | ||
| PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease | Q28212615 | ||
| Structural basis for Ca(2+)-induced activation of human PAD4 | Q28271512 | ||
| Human PAD4 regulates histone arginine methylation levels via demethylimination | Q28280359 | ||
| Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin | Q30425949 | ||
| Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach | Q33264597 | ||
| Immunity to citrullinated proteins in rheumatoid arthritis | Q34732863 | ||
| Posttranslational modifications of self-antigens | Q36193038 | ||
| Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? | Q36683135 | ||
| High mobility group proteins and their post-translational modifications | Q37015673 | ||
| Role of histone modifications in defining chromatin structure and function | Q37069217 | ||
| Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. | Q37217463 | ||
| A novel superfamily of enzymes that catalyze the modification of guanidino groups. | Q42656917 | ||
| Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes | Q43858818 | ||
| Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis | Q45091885 | ||
| Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis | Q46453983 | ||
| Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis | Q46680324 | ||
| Content of Citrulline and Other Amino-Acids in a Protein of Hair Follicles | Q59094246 | ||
| Occurrence of Citrulline in Proteins | Q79064459 | ||
| Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity | Q79843008 | ||
| Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents | Q81820607 | ||
| A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans | Q82132463 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1630-1640 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation | |
| P478 | volume | 62 |
| Q36474561 | Activation of PAD4 in NET formation |
| Q89174659 | Affinity Maturation Drives Epitope Spreading and Generation of Proinflammatory Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis |
| Q34190363 | Anti-CCP antibodies: the past, the present and the future |
| Q50969960 | Autoantibodies: double agents in human disease. |
| Q34969938 | Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity |
| Q37492376 | Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis |
| Q36509456 | Chemical Proteomic Platform To Identify Citrullinated Proteins |
| Q35722457 | Chemical biology of protein arginine modifications in epigenetic regulation |
| Q38263755 | Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms. |
| Q34947947 | Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53 |
| Q52932746 | Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. |
| Q40697747 | Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis |
| Q35202486 | Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology |
| Q92734113 | Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases |
| Q36588860 | Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity |
| Q60920704 | Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis |
| Q42054161 | Distorted Immunodominance by Linker Sequences or other Epitopes from a Second Protein Antigen During Antigen-Processing |
| Q37088914 | Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity |
| Q37534355 | Evolution of a mass spectrometry-grade protease with PTM-directed specificity. |
| Q36508933 | Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps |
| Q33952292 | Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4). |
| Q34575065 | Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidylarginine deiminase 4 |
| Q37465513 | Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. |
| Q40834260 | How citrullination invaded rheumatoid arthritis research |
| Q48005731 | Human Deiminases: Isoforms, Substrate Specificities, Kinetics, and Detection |
| Q38657171 | Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis |
| Q35984220 | Identification of citrullinated peptides in the synovial fluid of patients with rheumatoid arthritis using LC-MALDI-TOF/TOF. |
| Q39903023 | Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. |
| Q37982673 | In vivo relevance of citrullinated proteins and the challenges in their detection. |
| Q43218595 | Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire |
| Q42210248 | Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release. |
| Q93270547 | PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets |
| Q38747640 | PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis |
| Q47971862 | Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation |
| Q35825742 | Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis |
| Q35830530 | Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions |
| Q45137792 | Presence and role of anti-citrullinated protein antibodies in experimental arthritis models |
| Q86301346 | Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases |
| Q33729177 | Probing the Roles of Calcium-Binding Sites during the Folding of Human Peptidylarginine Deiminase 4. |
| Q38435747 | Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis |
| Q40895418 | The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis |
| Q38061870 | The protein arginine deiminases: Structure, function, inhibition, and disease. |
| Q44436437 | Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis |
Search more.